
北美糖组学市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品(酶、仪器、试剂盒和试剂)、应用(药物发现和开发、诊断、免疫学、癌症等)、和最终用户(制药和生物技术公司、学术和研究机构以及合同研究组织)
No. of Pages: 170 | Report Code: BMIRE00027262 | Category: Life Sciences
No. of Pages: 170 | Report Code: BMIRE00027262 | Category: Life Sciences
北美糖组市场预计将从 2022 年的598.44 百万美元增长到1,289.32 美元到 2028 年将达到 100 万;预计 2022 年至 2028 年复合年增长率为 13.6%。
随着科学家将精力集中在糖组学上,他们已经开始学习有关体内聚糖和糖基化功能的重要细节,包括细胞通讯,以及这些因素可能揭示的疾病发展和诊断信息。最大且增长最快的应用类别是药物发现和开发,这主要是由于制药和生物技术公司研发的增加以及大学研究机构药物发现研究活动的扩大。例如,2021 年 3 月,48Hour Discovery (48HD) 和 CQDM 宣布,两家公司获得了 80 万美元的奖励,用于利用其独特的药物发现平台进行肽药物开发。 CQDM Quantum Leap 计划鼓励对尖端技术、方法和平台进行研究,以加速或加快药物发现和开发,为这项为期两年的研究提供了资金。 CQDM 成员默克公司正在资助这项研究。阿尔伯塔大学和 48HD 将合作开展该项目。此外,GlycoNet(以阿尔伯塔大学糖组学研究中心为中心的卓越中心网络)正在提供资金,以提高加拿大人的生活质量。 2022 年 3 月,GlycoNet 的研究人员开发了一种治疗 Sanfilippo 综合征的新型组合药物,该药物显示出令人鼓舞的临床前结果。多项进展表明,糖组学有潜力提供快速、准确的诊断方法,超越不同的临床适应症和复杂的条件。因此,糖组学在该地区药物开发中的应用正在成为关键的市场驱动力。
凭借新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动北美糖组学市场。 北美糖组学市场预计在预测期内将以良好的复合年增长率增长。
北美糖组学市场收入及预测至 2028 年(百万美元)
< span>
北美糖组学市场已细分基于产品、应用、最终用户和国家/地区。根据产品,北美糖组学市场分为酶、仪器、试剂盒和试剂。酶细分市场将在 2022 年占据市场主导地位。酶细分市场进一步细分为糖苷酶、糖基转移酶、唾液酸转移酶、神经氨酸酶等。仪器部分还分为质谱仪、MALDI-TOF、HPLC、凝集素阵列、抗体阵列等。同样,试剂盒部分又分为聚糖释放试剂盒、聚糖标记试剂盒、聚糖纯化试剂盒等。此外,试剂部分分为寡糖、单糖、糖蛋白等。根据应用,北美糖组学市场分为药物发现和开发、诊断、免疫学、癌症等。药物发现和开发领域在 2022 年占据市场主导地位。根据最终用户,北美糖组学市场分为制药和制药。生物技术公司、学术界和研究机构和合同研究组织。制药及生物技术公司细分市场将在 2022 年占据主导地位。根据国家/地区,北美糖组市场分为美国、加拿大和墨西哥。 2022 年,美国将主导市场。
安捷伦科技公司;布鲁克公司;默克公司;新英格兰生物实验室; S-BIO(住友电木有限公司);岛津公司;宝生物公司;赛默飞世尔科技公司;和沃特世公司是北美糖组学市场的领先公司之一。
Strategic insights for North America Glycomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 598.44 Million |
Market Size by 2028 | US$ 1,289.32 Million |
Global CAGR (2022 - 2028) | 13.6% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Glycomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Glycomics Market is valued at US$ 598.44 Million in 2022, it is projected to reach US$ 1,289.32 Million by 2028.
As per our report North America Glycomics Market, the market size is valued at US$ 598.44 Million in 2022, projecting it to reach US$ 1,289.32 Million by 2028. This translates to a CAGR of approximately 13.6% during the forecast period.
The North America Glycomics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Glycomics Market report:
The North America Glycomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Glycomics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Glycomics Market value chain can benefit from the information contained in a comprehensive market report.